While it has been demonstrated that increased IGF-1 serum levels contribute to tumor development and progression in colon cancer cells [119,120], the association between serum adiponectin concentration and the increased risk of colon cancer, carcinogenesis, or cancer progression has not been completely elucidated until now [121]. Here, ADIPOQ is linked to neoplasm.